What is the initial push pressor dosing for pediatric symptomatic bradycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For pediatric symptomatic bradycardia, the initial push pressor dose is atropine 0.02 mg/kg, with a minimum single dose of 0.1 mg and a maximum single dose of 0.5 mg for a child, which can be repeated every 5 minutes to a maximum total dose of 1 mg for a child, as recommended by the Pediatrics journal in 2008 1. The dose of atropine for pediatric symptomatic bradycardia is crucial for effective management.

  • The initial dose of 0.02 mg/kg is based on the patient's weight, ensuring that the minimum single dose is not less than 0.1 mg and the maximum single dose does not exceed 0.5 mg for children.
  • The dose can be repeated every 5 minutes, with a maximum total dose of 1 mg for children, allowing for titration based on clinical response.
  • It is essential to note that atropine is used in the context of symptomatic bradycardia, particularly when oxygenation and ventilation are not effective in treating hypoxia-induced bradycardia, as stated in the study 1.
  • Epinephrine, as mentioned in other contexts, is also a critical medication in pediatric resuscitation but is specifically indicated for cases where oxygen and adequate ventilation are not effective in the treatment of hypoxia-induced bradycardia, with dosing guidelines provided separately.
  • The choice between atropine and epinephrine depends on the underlying cause of the bradycardia and the clinical scenario, with atropine being particularly useful in cases of increased vagal tone or primary AV block.
  • The study 1 provides comprehensive guidelines for the management of pediatric emergencies, including the use of atropine for symptomatic bradycardia, emphasizing the importance of appropriate dosing and administration routes.

From the FDA Drug Label

2.3 Pediatric Dosage Dosing in pediatric populations has not been well studied. Usual initial dose is 0.01 to 0.03 mg/kg. The initial push pressor dosing for pediatric symptomatic bradycardia with atropine (IV) is 0.01 to 0.03 mg/kg 2.

  • Key points:
    • Dosing has not been well studied in pediatric populations.
    • The dose should be titrated based on heart rate, PR interval, blood pressure, and symptoms.

From the Research

Initial Push Pressor Dosing for Pediatric Symptomatic Bradycardia

  • The initial push pressor dosing for pediatric symptomatic bradycardia is not explicitly stated in the provided studies.
  • However, according to the study 3, the emergency treatment of bradycardia depends on its hemodynamic consequences, and if the heart rate is <60 beats per minute with poor perfusion despite effective ventilation with oxygen, it may be treated with chest compressions, epinephrine through IV or endotracheal tube.
  • The study 4 mentions that early bolus epinephrine administration during pediatric cardiopulmonary resuscitation for bradycardia with poor perfusion was not associated with survival outcomes, but it does not provide specific dosing information.
  • The American Heart Association (AHA) Pediatric Advanced Life Support (PALS) guidelines, mentioned in the study 5, recommend interventions such as oxygen, chest compressions, epinephrine, and atropine for pediatric bradycardia, but the specific dosing for push pressor is not provided.

Recommended Interventions

  • The studies suggest that the choice of therapy for pediatric bradycardia depends on the patient's degree of hemodynamic instability 3, 5.
  • Atropine may be beneficial in cases of bradycardia due to vagal stimulation or primary A-V block 3, 6.
  • Epinephrine and isoproterenol may be considered for continuous infusion if bradycardia persists or responds only transiently to initial treatment 3.
  • Transcutaneous pacing may be planned for emergency treatment of bradycardia 3.

Related Questions

What is the dose of glucagon for symptomatic bradycardia (abnormally slow heart rate)?
What is the most likely diagnosis for a 3-month-old infant with palpitations, a narrow complex QRS (quantitative residential survey), absent P wave, and a regular rhythm on electrocardiogram (ECG)?
What is the next best step in managing a patient with symptomatic bradycardia (abnormally slow heart rate), shortness of breath, and fatigue, with a history of diabetes (diabetes mellitus) and hypertension (high blood pressure)?
What is the initial treatment for symptomatic bradycardia in the Advanced Cardiovascular Life Support (ACLS) setting?
What are the differential diagnoses for a 38-year-old patient who experienced a syncopal episode with bradycardia and hypotension in post-surgical daycare following umbilical hernia repair, and responded to Atropine (atropine)?
What are the differences between Pfizer (Comirnaty) and Moderna (mRNA-1273) Covid-19 vaccines in terms of recommended use?
What is the usefulness of a rectal exam (digital rectal examination, DRE) in diagnosing gastrointestinal (GI) bleeding?
What is the sensitivity of Digital Rectal Examination (DRE) for detecting gastrointestinal (GI) bleeding?
What is the risk of hemorrhagic transformation with tissue plasminogen activator (tPA) in ischemic stroke?
What is the recommended dose and administration of epinephrine (adrenaline) in a clinical setting?
How does a diagnosis of pulmonary embolism (PE) or a ruled out deep vein thrombosis (DVT) by ultrasound (US) influence the decision to get a cat?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.